Use of anti-claudin-1 antibodies to treat cholangiopathies
US-2026055179-A1 · Feb 26, 2026 · US
This page is not indexed by search engines while we improve data quality.
Iacone Roberto patents
Iacone Roberto is listed as an inventor on 27 patents in our database. Major assignees and classification codes are summarized below.
| Metric | Value |
|---|---|
| Inventor | Iacone Roberto |
| Total patents | 27 |
| First publication | Jan 15, 2015 |
| Latest publication | Feb 26, 2026 |
Notable patents
Publications ranked by popularity score, then publication date.
Treatment of drug-resistant hepatocellular carcinoma
US-2026015416-A1 · Jan 15, 2026 · US
Use of anti-claudin-1 antibodies to treat cholangiocarcinoma
US-2025326835-A1 · Oct 23, 2025 · US
Anti-claudin-1 monoclonal antibodies for the prevention and treatment of fibrotic diseases
US-2023138047-A1 · May 4, 2023 · US
Antisense oligonucleotides for modulating htra1 expression
US-2022042022-A1 · Feb 10, 2022 · US
Difluoroketamide derivatives as HtrA1 inhibitors
US-11059858-B2 · Jul 13, 2021 · US
Trifluoromethylpropanamide derivatives as HTRA1 inhibitors
US-11014963-B2 · May 25, 2021 · US
Antisense oligonucleotides for modulating htra1 expression
US-2020399641-A1 · Dec 24, 2020 · US
Companion diagnostic for htra1 rna antagonists
US-2020378970-A1 · Dec 3, 2020 · US
Small molecule based conversion of somatic cells into neural crest cells
US-10724000-B2 · Jul 28, 2020 · US
Recent patents
Latest publications not already listed above.
Method for differentiation of pluripotent stem cells into vascular bed cells
US-2020182861-A1 · Jun 11, 2020 · US
Antisense oligonucleotides for modulating htra1 expression
US-2020157546-A1 · May 21, 2020 · US
Antisense oligonucleotides for modulating HTRA1 expression
US-10519450-B2 · Dec 31, 2019 · US
Difluoroketamide derivatives
US-10428108-B2 · Oct 1, 2019 · US
Antisense oligonucleotides for modulating htra1 expression
US-2019055564-A1 · Feb 21, 2019 · US
Trifluoromethylpropanamide derivatives as htra1 inhibitors
US-2018371016-A1 · Dec 27, 2018 · US
New difluoroketamide derivatives as htra1 inhibitors
US-2018371015-A1 · Dec 27, 2018 · US
Method for differentiation of pluripotent stem cells into multi-competent renal precursors
US-10138468-B2 · Nov 27, 2018 · US
Trifluoromethylpropanamide derivatives
US-9980929-B2 · May 29, 2018 · US
New difluoroketamide derivatives
US-2018057526-A1 · Mar 1, 2018 · US
Antisense oligonucleotides for modulating htra1 expression
US-2018002701-A1 · Jan 4, 2018 · US
New trifluoromethylpropanamide derivatives
US-2017348257-A1 · Dec 7, 2017 · US
Small molecule based conversion of somatic cells into neural crest cells
US-2016369233-A1 · Dec 22, 2016 · US
Conversion of somatic cells to induced reprogrammed neural stem cells (irnscs)
US-2016369234-A1 · Dec 22, 2016 · US
Method for differentiation of pluripotent stem cells into multi-competent renal precursors
US-2016145578-A1 · May 26, 2016 · US
Conversion of somatic cells to induced reprogrammed neural stem cells (irNSCs)
US-9297025-B2 · Mar 29, 2016 · US
Method for differentiation of pluripotent stem cells into vascular bed cells
US-2015017674-A1 · Jan 15, 2015 · US
Major assignees
Companies most often associated with this inventor's publications.
| Assignee | Patents |
|---|---|
| Hoffmann La Roche | 19 |
| Hoffmann La Roche | 5 |
| Alentis Therapeutics Ag | 4 |
| Univ Strasbourg | 4 |
| Inst Nat Sante Rech Med | 4 |
Top CPC classifications
Most common classification codes across this inventor's patents.